Pharmaceutical Technology17d
USPTO allows patents for Remedy’s large hemispheric infarction drug
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating LHI.
Le Lézard18d
Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
The Victoria Advocate18d
Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
EVT has recently become the standard of care in treating LHI. Clinical evidence has shown ... expected to be included in the primary analysis group of any Phase 3 study designed to gain regulatory ...
Insider25d
London (Small) Best Companies to Work For 2020
The final score is normalised for company size band and calculated out of 1000. 6 EngageTech RBCI: 783.8 7 LHi Group RBCI: 782.9 8 Gate One RBCI: 781.6 9 Annapurna Recruitment RBCI: 773.0 10 tails.com ...